07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
The September 19, 2019 edition of the Federal Register includes the updated minimum wage rates that ...
Read More >
What Happened: • The Federal Trade Commission (FTC), along with the Antitrust Division of the Depa...
Read More >
Some interesting links we found across the web this week: How Some Founders are Raising Capital Out...
Read More >
Obermayer is excited to introduce its new “GovCon Examiner Live” webinar series, your resource fo...
Read More >
In 2017, the IRS significantly limited the ability of plan sponsors to request a determination lette...
Read More >
Grant Bux, Big Daddy Bux’s nephew, owns Sparkle-Plenty Electrical Manufacturing in Dallas, and has ...
Read More >